纵向评估三种血清生物标志物检测极早期肝细胞癌
在689例肝硬化或慢性乙型肝炎患者中,42例肝细胞癌(HCC)患者按1:4匹配168例对照。诊断时AFP、AFP-L3、DCP的AUROC分别为0.77、0.73、0.71,AFP联合AFP-L3的AUROC为0.83。以AFP 5 ng/mL、AFP-L3 4%为最佳截断值,联合检测的灵敏度和特异度分别为79%和87%,AFP联合AFP-L3使超声灵敏度从48.6%提高至94.3%。
要点
- 在极早期HCC(单个<2 cm)占73.8%的病例中,AFP联合AFP-L3的AUROC为0.83,优于单一标志物。
- 以AFP 5 ng/mL和AFP-L3 4%为截断值,AFP联合AFP-L3检测HCC的灵敏度为79%、特异度为87%。
- 超声联合AFP和AFP联合AFP-L3分别使超声灵敏度从48.6%提高至88.6%和94.3%。
核心结论
- 在三种生物标志物中,AFP在区分HCC病例与对照方面表现最佳;采用截断值(分别为5 ng/mL和4%)的AFP联合AFP-L3显著提高了检测极早期HCC的灵敏度。
研究设计与样本
- 研究纳入参与四项前瞻性研究的689例肝硬化或慢性乙型肝炎患者,其中42例诊断为HCC,按年龄、性别、病因、肝硬化和随访时长以1:4比例匹配168例对照。
- 比较病例与对照在HCC诊断时、诊断前6个月和诊断前12个月的AFP、AFP-L3和DCP水平。
主要发现
- 42例HCC中,39例(93%)有肝硬化,36例(85.7%)丙氨酸氨基转移酶水平正常,31例(73.8%)为极早期HCC(单个<2 cm)。
- 病例组AFP和AFP-L3从HCC诊断前6个月开始升高(P < 0.05),而对照组保持不变。
- HCC诊断时,AFP、AFP-L3和DCP的受试者工作特征曲线下面积(AUROCs)分别为0.77、0.73和0.71。
- AFP联合AFP-L3的AUROC更高(0.83),而加入DCP未进一步改善AUROC(0.86)。
- 以最佳截断值(AFP 5 ng/mL;AFP-L3 4%),AFP联合AFP-L3的灵敏度和特异度分别为79%和87%。
关键数值与推荐
- AFP的最佳截断值为5 ng/mL,AFP-L3的最佳截断值为4%。
- 采用上述截断值时,AFP联合AFP-L3检测HCC的灵敏度为79%,特异度为87%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We aimed to determine the surveillance performance of alpha-fetoprotein (AFP), lectin-reactive AFP (AFP-L3), des-gamma-carboxy prothrombin (DCP), and their combinations for the early detection of hepatocellular carcinoma (HCC) by using prospectively collected longitudinal samples in patients at risk. Among 689 patients with cirrhosis and/or chronic hepatitis B who participated in four prospective studies, 42 HCC cases were diagnosed, selected, and matched with 168 controls for age, sex, etiology, cirrhosis, and duration of follow-up in a 1:4 ratio. Levels of AFP, AFP-L3, and DCP at the time of HCC diagnosis, month -6, and month -12 were compared between cases and controls. Of 42 HCC cases, 39 (93%) had cirrhosis, 36 (85.7%) had normal alanine aminotransferase levels, and 31 (73.8%) had very early-stage HCC (single <2 cm). AFP and AFP-L3 began to increase from 6 months before diagnosis of HCC in cases (P < 0.05), while they remained unchanged in controls. At HCC diagnosis, the area under the receiver operator characteristic curves (AUROCs) for AFP, AFP-L3, and DCP were 0.77, 0.73, and 0.71, respectively. Combining AFP and AFP-L3 showed a higher AUROC (0.83), while adding DCP did not further improve the AUROC (0.86). With the optimal cutoff values (AFP, 5 ng/mL; AFP-L3, 4%), the sensitivity and specificity of AFP and AFP-L3 combination were 79% and 87%, respectively. The sensitivity of ultrasonography was 48.6%, which was increased to 88.6% and 94.3% by adding AFP and AFP + AFP-L3, respectively. Conclusion: Among three biomarkers, AFP showed the best performance in discriminating HCC cases from controls; the AFP and AFP-L3 combination, adopting cutoff values (5 ng/mL and 4%, respectively), significantly improved the sensitivity for detecting HCC at a very early stage.
引用
- Choi J, Kim GA, Han S, et al. Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma. Hepatology. 2019. PMID: 30153338. doi:10.1002/hep.30233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。